Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Clinton C Mason

Showing results (31-40 of 36) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 36 results.
JAMA Oncology|August 19, 2021
Association of Combined Focal 22q11.22 Deletion and IKZF1 Alterations With Outcomes in Childhood Acute Lymphoblastic LeukemiaDavid Spencer Mangum, Julia A Meyer, Clinton C Mason, et al.
Cancer|December 26, 2022
Multicenter study of pediatric Epstein-Barr virus-negative monomorphic post solid organ transplant lymphoproliferative disordersZeinab A M Afify, Mary M Taj, Manuela Orjuela-Grimm, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 20, 2018
Nuclear-Cytoplasmic Transport Is a Therapeutic Target in MyelofibrosisDongqing Yan, Anthony D Pomicter, Srinivas Tantravahi, et al.
Leukemia|August 20, 2014
Combined STAT3 and BCR-ABL1 inhibition induces synthetic lethality in therapy-resistant chronic myeloid leukemiaAnna M Eiring, Brent D G Page, Ira L Kraft, et al.
Clinical and Translational Medicine|December 19, 2022
Loss of G0/G1 switch gene 2 (G0S2) promotes disease progression and drug resistance in chronic myeloid leukaemia (CML) by disrupting glycerophospholipid metabolismMayra A Gonzalez, Idaly M Olivas, Alfonso E Bencomo-Alvarez, et al.
Blood Cancer Discovery|May 24, 2021
SIRT5 IS A DRUGGABLE METABOLIC VULNERABILITY IN ACUTE MYELOID LEUKEMIADongqing Yan, Anca Franzini, Anthony D Pomicter, et al.
Pageof 4

Showing results (31-40 of 36) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 36 results.
JAMA Oncology|August 19, 2021
Association of Combined Focal 22q11.22 Deletion and IKZF1 Alterations With Outcomes in Childhood Acute Lymphoblastic LeukemiaDavid Spencer Mangum, Julia A Meyer, Clinton C Mason, et al.
Cancer|December 26, 2022
Multicenter study of pediatric Epstein-Barr virus-negative monomorphic post solid organ transplant lymphoproliferative disordersZeinab A M Afify, Mary M Taj, Manuela Orjuela-Grimm, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 20, 2018
Nuclear-Cytoplasmic Transport Is a Therapeutic Target in MyelofibrosisDongqing Yan, Anthony D Pomicter, Srinivas Tantravahi, et al.
Leukemia|August 20, 2014
Combined STAT3 and BCR-ABL1 inhibition induces synthetic lethality in therapy-resistant chronic myeloid leukemiaAnna M Eiring, Brent D G Page, Ira L Kraft, et al.
Clinical and Translational Medicine|December 19, 2022
Loss of G0/G1 switch gene 2 (G0S2) promotes disease progression and drug resistance in chronic myeloid leukaemia (CML) by disrupting glycerophospholipid metabolismMayra A Gonzalez, Idaly M Olivas, Alfonso E Bencomo-Alvarez, et al.
Blood Cancer Discovery|May 24, 2021
SIRT5 IS A DRUGGABLE METABOLIC VULNERABILITY IN ACUTE MYELOID LEUKEMIADongqing Yan, Anca Franzini, Anthony D Pomicter, et al.
Pageof 4